Type 2 diabetes patients with NAFLD often suffered from glucose and lipid metabolism disorder, and present with abnormally high fasting blood glucose, fasting insulin and HOMA-IR [25]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.